ask="100.00"
ask_size="600"
average_daily_volume="290544"
bid="20.15"
bid_size="100"
book_value="3.79"
change="-0.11"
change_from_200_day_moving_average="2.88"
change_from_50_day_moving_average="-1.63"
change_from_52_week_high="-4.87"
change_From_52_week_low="12.81"
change_in_percent="-0.41%"
close="26.93"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="14358000"
high="27.30"
high_52_weeks="31.80"
last_trade_date="1/27/2017"
last_trade_price="26.93"
last_trade_size="1644"
last_trade_time="4:00pm"
low="26.54"
low_52_weeks="14.12"
market_capitalization="577.16M"
moving_average_200_day="24.05"
moving_average_50_day="28.56"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="26.90"
pe_ratio="N/A"
peg_ratio="-0.19"
percent_change_from_200_day_moving_average="+11.96%"
percent_change_from_50_day_moving_average="-5.72%"
percent_change_from_52_week_high="-15.31%"
percent_change_from_52_week_low="+90.72%"
previous_close="27.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.14"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="7.04"
stock_exchange="NMS"
symbol="ACRS"
volume="64472"
weeks_range_52="14.12 - 31.80"
